Assessment of the oncological outcomes of three different bacillus Calmette-Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer.
Łukasz NowakWojciech KrajewskiMarco MoschiniJoanna ChorbińskaSławomir PoletajewAndrzej TukiendorfTim MuilwijkSteven JoniauAlessandro TafuriAlessandro AntonelliRossella OrlandoEttore Di TrapaniMario Alvarez-MaestroGiuseppe SimoneStefania ZamboniClaudio SimeoneMaria Cristina MarconiRiccardo MastroianniRadosław PiszczekEvanguelos XylinasRomuald Zdrojowynull nullPublished in: Arab journal of urology (2021)
: The results of the present study suggest that the Moreau and TICE strains might be superior to the RIVM strain in terms of RFS in patients with T1HG NMIBC.Abbreviations: CIS: carcinoma in situ; IPW: inverse probability weighting; IQR: interquartile range; HR: hazard ratio; HG: high grade; LVI: lymphovascular invasion; MP: muscularis priopria; NMIBC: non-muscle-invasive bladder cancer; PFS: progression-free survival; RCT: randomised controlled trial; RFS: recurrence-free survival; T1HG, high-grade T1; (re-)TURB: (re-staging) transurethral resection of bladder; VH: variant histology.
Keyphrases
- muscle invasive bladder cancer
- free survival
- high grade
- low grade
- fluorescent probe
- escherichia coli
- aqueous solution
- living cells
- lymph node
- study protocol
- spinal cord injury
- rectal cancer
- randomized controlled trial
- squamous cell carcinoma
- clinical trial
- lymph node metastasis
- bacillus subtilis
- robot assisted
- urinary tract
- benign prostatic hyperplasia
- double blind
- glycemic control